FreeGuest Editorial NCI’s Cancer Prevention-Interception Targeted Agent Discovery (CAP-IT) Program, a milestone in cancer prevention research December 21, 2022Vol.48 No.46By Margie Clapper
EditorialFree Top 25 stories of 2022 December 21, 2022Vol.48 No.46By Alexandria Carolan and Katie Goldberg
NCI BSA approves eight new, reissue concepts at BSA/NCAB joint meeting December 16, 2022Vol.48 No.45By Jacquelyn Cobb
In the Archives The National Cancer Act 20 years later: impact as seen by its architects in 1991 December 16, 2022Vol.48 No.45
Conversation with The Cancer LetterFree NCI Director Monica Bertagnolli has breast cancer“I have more motivation to get up every morning to keep doing what I do” December 14, 2022Vol.48 No.45By Paul Goldberg and Matthew Bin Han Ong
NCI’s Bertagnolli & ARPA-H’s Wegrzyn have been plotting to make the most of their strengths and differences December 09, 2022Vol.48 No.44By Matthew Bin Han Ong
Guest Editorial PAMN: How cancer centers develop ways to communicate the value of research December 09, 2022Vol.48 No.44By Heidi Findlay
FDA, NCI align to simplify clinical research, producing a model “pragmatic” registration trial in NSCLC December 02, 2022Vol.48 No.43By Jacquelyn Cobb, Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer Letter Roy Herbst: I hope Pragmatica-Lung will become the norm December 02, 2022Vol.48 No.43By Jacquelyn Cobb and Paul Goldberg
Conversation with The Cancer Letter Ellen Sigal: Pragmatica-Lung may be a model for other trials that are unnecessarily complex December 02, 2022Vol.48 No.43By Matthew Bin Han Ong
